Keywords
Abstract
Ushbu maqolada so‘lak bezlari kasalliklarining etiologik omillari, klinik belgilarining o‘ziga xos jihatlari, zamonaviy diagnostika usullari va davolash tamoyillari tahlil qilinadi. So‘lak bezlari patologiyasi organizmning yallig‘lanish, obstruktiv, autoimmun va o‘smali jarayonlari bilan bog‘liq bo‘lib, ularning kechishi ko‘pincha og‘riq, shish va sekretsiya buzilishlari bilan kechadi. Maqolada shuningdek, sialolitiaz, sialoadenit, Sjogren sindromi va pleomorf adenom kabi kasalliklarning patogeneziga ilmiy yondashuvlar keltiriladi.
References
1. Ten Cate A.R. Oral Histology: Development, Structure, and Function. 9th ed. Elsevier, 2019.
2. Junqueira L.C., Carneiro J. Basic Histology: Text & Atlas. McGraw-Hill, 2021.
3. Dawes C. Salivary flow and composition in health and disease. J Dent Res, 2020.
4. Humphrey S.P., Williamson R.T. A review of saliva: normal composition, flow, and function. J Clin Dent, 2001.
5. Pedersen A.M.L. et al. Salivary glands and saliva in health and disease. J Oral Pathol Med, 2018.
6. Iro H., Zenk J. Salivary gland diseases in the era of sialendoscopy: diagnostic and therapeutic standards. HNO, 2013.
7. Nahlieli O. et al. Sialolithiasis: a comprehensive analysis and surgical approach. J Oral Maxillofac Surg, 2015.
8. Fox R.I. Sjogren’s syndrome. Lancet, 2005.
9. Mandel L. Sialadenitis: etiology, diagnosis, and treatment. J Am Dent Assoc, 2017.
10. Witt R.L. Imaging of salivary gland tumors. Otolaryngol Clin N Am, 2016.
11. Zenk J. et al. New diagnostic methods in salivary gland diseases. Laryngoscope, 2012.
12. Koch M., Iro H. Modern management of salivary gland diseases. Springer, 2020.
13. Mandel L. Sialadenitis: etiology, diagnosis, and treatment. J Am Dent Assoc, 2017.
14. Zenk J. et al. Acute and chronic sialadenitis – new approaches to diagnosis and therapy. Otolaryngol Pol, 2014.
15. Koch M., Iro H. Modern management of salivary gland diseases. Springer, 2020.
16. Gallo A. et al. Recurrent parotitis: pathogenesis and therapeutic strategies. Acta Otorhinolaryngol Ital, 2016.
17. Eveson J.W., Cawson R.A. Salivary gland pathology. Blackwell Scientific, 2019.
18. Marchal F. et al. Salivary gland inflammatory diseases: diagnosis and endoscopic management. Ann Otol Rhinol Laryngol, 2018.
19. Iro H., Zenk J. Diagnostic imaging of salivary gland diseases. Springer, 2018.
20. Levy DM, Remine WH, Devine KD. Salivary gland calculi: Pain, swelling associated with eating. JAMA. 1962;181:1115–1119.
21. Bodner L. Salivary gland calculi: diagnostic imaging and surgical management. Compendium. 1993;14(5):572–576.
22. Hiraide F, Nomura Y. The fine surface structure and composition of salivary calculi. Laryngoscope. 1980;90(1):152–158.
23. Mandel L. Mechanisms of salivary stone formation. J Oral Pathol Med. 2015;44(6):459–464.
24. Marchal F., Dulguerov P. Interventional sialendoscopy. N Engl J Med. 1999;341(16):1242–1243.
25. Witt RL, Iro H., McGurk M. Minimally invasive options for salivary calculi. Laryngoscope. 2012;122(6):1306–1311.
26. Luers JC. et al. Sialendoscopy for sialolithiasis: early treatment, better outcome. Head Neck. 2012;34(4):499–504.
27. Iro H., Koch M. Diagnostic imaging of salivary glands. Springer, 2018.
28. Zenk J. et al. Sialendoscopy in the diagnosis and treatment of sialolithiasis. Otolaryngol Head Neck Surg. 2012;147(5):858–863.
29. Fox R.I. Sjögren’s syndrome. Lancet, 2005.
30. Ramos-Casals M. et al. Epidemiology and clinical spectrum of Sjögren’s syndrome. Ann Rheum Dis, 2009.
31. Jonsson R. et al. Pathogenesis of Sjögren’s syndrome: from autoantibodies to B-cell hyperactivity. J Autoimmun, 2013.
32. Tsubota K. et al. Immunopathology of Sjögren’s syndrome. Invest Ophthalmol Vis Sci, 2012.
33. Li X. et al. Genetic risk factors for Sjögren’s syndrome. Rheumatology, 2017.
34. Daniels T.E. Clinical manifestations of primary Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014.
35. Bowman S.J. Systemic aspects of primary Sjögren’s syndrome. Curr Opin Rheumatol, 2017.
36. Vitali C. et al. Classification criteria for Sjögren’s syndrome: revised international consensus. Ann Rheum Dis, 2016.
37. Shiboski C.H. et al. 2016 ACR-EULAR classification criteria for Sjögren’s syndrome. Arthritis Rheumatol, 2017.
38. [47] Pinkston J.A., Cole P. Incidence rates of salivary gland tumors. Otolaryngol Head Neck Surg, 1999.
39. Spiro R.H. Salivary neoplasms: overview of 35-year experience. Head Neck Surg, 1986.
40. de Oliveira F.A. et al. Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol, 2009.
41. Califano J., Eisele D.W. Benign salivary gland neoplasms. Otolaryngol Clin North Am, 1999.
42. Simental A., Carrau R.L. Malignant neoplasms of the salivary glands. Cummings Otolaryngology, 2004.
43. Persson M. et al. Recurrent gene fusions in salivary gland tumors. J Pathol, 2012.
44. Witt R.L. et al. Smoking and Warthin’s tumor: a clinical correlation. Laryngoscope, 2010.
45. WHO Classification of Head and Neck Tumours, 2017.
46. Zbaren P. et al. Pleomorphic adenoma of the parotid gland: surgical management. Ann Otol Rhinol Laryngol, 2001.
47. McGurk M. et al. Warthin tumor: epidemiology and treatment outcomes. J Laryngol Otol, 2005.
48. Dardick I. Salivary gland monomorphic adenomas. Mod Pathol, 2004.
49. Goode R.K. et al. Mucoepidermoid carcinoma: grading and prognosis. Am J Surg Pathol, 2001.
50. Ellis G.L. Acinic cell carcinoma of salivary glands. Oral Surg Oral Med Oral Pathol, 1996.
51. Seethala R.R. Low-grade salivary gland carcinomas: review and update. Head Neck Pathol, 2009.